AI assistant
Lifecare ASA — Share Issue/Capital Change 2022
Nov 3, 2022
3654_rns_2022-11-03_8fb965bd-56ff-45c4-8dfb-59ac3ef53e6f.html
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Lifecare AS – New share capital registered
Lifecare AS – New share capital registered
Reference is made to the stock exchange announcement published on 26 October 2022 by Lifecare AS (the "Company") announcing the successful completion of a private placement of new shares in the Company, with gross proceeds of NOK 45 million (the "Private Placement").
The share capital increase related to the Private Placement has been registered in the Norwegian Register of Business Enterprises, and the Company's new registered share capital is NOK 47,146,296.80 divided into 117,865,742 shares, each with a par value of NOK 0.40.
For further information, please contact:
Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.This stock exchange announcement was published by Joacim Holter, CEO at Lifecare AS, on 03.11.2022 at 21.58 CET.
This is Lifecare
Lifecare is a Bergen-based technology company developing a miniaturized implantable long-term sensor for correct and continuous monitoring of blood sugar in people with diabetes. The Company's patented technology also has the potential for use in various biomarkers. Lifecare AS is listed on Euronext Growth (LIFE).